---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-235955"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-10-10T23:59:59+00:00"
generated_at: "2026-05-30T16:52:15.553954+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences enters $20M PIPE with Toonon Partners for Series A Preferred Stock

## Summary
- Agreed to issue 222,222 Series A Preferred shares at $90/share to Toonon Partners for $20M total.
- Proceeds to fund working capital after closing of business combination with OSR Holdings.
- Series A Preferred carries 5% annual dividend, convertible into common at $9.00/share.
- Company has redemption option after 1 year at 7% accrued; holders after 3 years.
- PIPE closing conditioned on business combination completion and filing of Certificate of Designations.

## SEC filing metadata
- accession: 0001193125-24-235955
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312524235955/0001193125-24-235955-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312524235955/d881808d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-235955
- JSON: https://secwatch.observer/filing/0001193125-24-235955.json
- Plain text: https://secwatch.observer/filing/0001193125-24-235955.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.